G1 Therapeutics, Inc. Quarterly Depreciation in USD from Q2 2016 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
G1 Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q2 2016 to Q2 2024.
  • G1 Therapeutics, Inc. Depreciation for the quarter ending June 30, 2024 was $121K, a 6.92% decline year-over-year.
  • G1 Therapeutics, Inc. Depreciation for the twelve months ending June 30, 2024 was $881K, a 63.8% increase year-over-year.
  • G1 Therapeutics, Inc. annual Depreciation for 2022 was $530K, a 13% increase from 2021.
  • G1 Therapeutics, Inc. annual Depreciation for 2021 was $469K, a 19.4% decline from 2020.
  • G1 Therapeutics, Inc. annual Depreciation for 2020 was $582K, a 63.5% increase from 2019.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $881K $121K -$9K -6.92% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $890K $120K -$12K -9.09% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $902K $513K +$376K +274% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $526K $127K -$12K -8.63% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $538K $130K -$9K -6.48% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $547K $132K +$17K +14.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 $530K $137K +$23K +20.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $507K $139K +$22K +18.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $485K $139K +$21K +17.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $464K $115K -$5K -4.17% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $469K $114K -$45K -28.3% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $514K $117K -$28K -19.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $542K $118K -$40K -25.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $582K $120K -$39K -24.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $621K $159K +$18K +12.8% Oct 1, 2020 Dec 31, 2020 10-Q 2021-05-05
Q3 2020 $603K $145K +$59K +68.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $544K $158K +$93K +143% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $451K $159K +$95K +148% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $356K $141K +$81K +135% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-23
Q3 2019 $275K $86K +$38K +79.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $237K $65K +$30K +85.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $207K $64K +$32K +100% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $175K $60K +$30K +100% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-24
Q3 2018 $145K $48K +$21K +77.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $124K $35K +$15K +75% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $109K $32K +$20K +167% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $89K $30K Oct 1, 2017 Dec 31, 2017 10-K 2020-02-26
Q3 2017 $27K +$9K +50% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $20K +$7K +53.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $12K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-03
Q3 2016 $18K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $13K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.